TIDMACRL

RNS Number : 0050X

Accrol Group Holdings PLC

25 August 2020

25 August 2020

ACCROL GROUP HOLDINGS PLC

("Accrol", the "Group" or the "Company")

AIM: ACRL

NOTICE OF RESULTS AND INVESTOR PRESENTATION

For the year ended 30 April 2020

Notice of Results

Accrol, the UK's leading independent tissue converter, is pleased to announce that its Audited Final Results for the year ended 30 April 2020 will be published on Wednesday, 2 September 2020.

Investor Meet Company Presentation

Accrol is committed to communicating with all investors equally and directly, to ensure that its strategy, business model and performance are clearly understood. Accordingly, a part of the Group's Final Results roadshow, an online presentation for all interested parties will be hosted by management via the Investor Meet Company ("IMC") platform. This will take place at 13.15 hours on Friday, 4 September 2020.

To participate, you must register with IMC at https://www.investormeetcompany.com/accrol-group-holdings-plc/register-investor . Those who have already registered interest in Accrol with IMC will be invited automatically.

Questions may be submitted ahead of the event, through the IMC dashboard, or at any time during the live presentation, via the "Ask a Question" function. Whilst the management may not be in a position to answer all questions, the team will endeavour to answer the most pertinent ones within the confines of the information already disclosed to the market.

The presentation and Q&A responses will be available on the IMC platform at the earliest opportunity post-event.

 
For further information, please contact: 
 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman            Via Belvedere Communications 
Gareth Jenkins, Chief Executive Officer 
 
Zeus Capital Limited (Nominated Adviser 
 & Broker) 
Dan Bate / Jordan Warburton                  Tel: +44 (0) 161 831 1512 
Dominic King / John Goold                    Tel: +44 (0) 203 829 5000 
 
Liberum Capital Limited (Joint Broker)       Tel: +44 (0) 20 3100 2222 
Clayton Bush 
Edward Thomas 
 
Belvedere Communications Limited 
Cat Valentine                                Tel: +44 (0) 7715 769 078 
Keeley Clarke                                Tel: +44 (0) 7967 816 525 
Llew Angus                                   Tel: +44 (0) 7407 023 147 
                                              accrolpr@belvederepr.com

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. The business operates from four sites in Lancashire:

 
--  A manufacturing, storage and distribution facility in Blackburn; 
--  A storage and administrative centre in Blackburn; 
--  A facial tissue plant, also in Blackburn; and 
--  A manufacturing, storage and distribution facility in Leyland.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORPPUMCRUPUGCC

(END) Dow Jones Newswires

August 25, 2020 02:00 ET (06:00 GMT)

Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Accrol Charts.
Accrol (LSE:ACRL)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Accrol Charts.